Complete Filing Data
Artius II Acquisition Inc. reported Stockholders Equity of -$13.79 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Artius II Acquisition Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 |
|---|---|
| Net Income Loss | $136.2K |
| Operating Income Loss | -$7.9M |
| General And Administrative Expense | $1.9M |
| General And Administrative Costs Paid By Sponsor In Exchange For Issuance Of Ordinary Shares | -8.1M |
| Other Nonoperating Income Expense | $8.1M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 |
|---|---|---|---|---|
| Net Income Loss | $2.2M | $2.1M | -$5.1M | -$50.1K |
| Operating Income Loss | -$240.8K | -$219.6K | -$6.1M | -$50.1K |
| General And Administrative Expense | $240.8K | $219.6K | $141.5K | $50.1K |
| General And Administrative Costs Paid By Sponsor In Exchange For Issuance Of Ordinary Shares | 1.1M | 0.00 | ||
| Other Nonoperating Income Expense | $2.5M | $0.00 |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 |
|---|---|---|
| Stockholders Equity | -$13.8M | -$60.3K |
| Deferred Underwriting Fee | $6.6M | $0.00 |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $32.2K | $0.00 |
| Retained Earnings Accumulated Deficit | -$13.8M | -$85.3K |
| Preferred Stock Value | $0.00 | $0.00 |
| Notes Payable Current | $0.00 | $127.6K |
| Liabilities Current | $1.4M | $563.9K |
| Liabilities And Stockholders Equity | $228.3M | $503.7K |
| Liabilities | $14.0M | $563.9K |
| Deferred Costs | $0.00 | $503.7K |
| Assets Held In Trust Noncurrent | $228.1M | $0.00 |
| Assets Current | $188.9K | $0.00 |
| Assets | $228.3M | $503.7K |
| Advisory Fee Payable | $6.0M | $0.00 |
| Accrued Liabilities Current | $1.3M | $35.0K |
| Accounts Payable Underwriters Promoters And Employees Other Than Salaries And Wages Current | $86.9K | $401.4K |
| Repayments Of Related Party Debt | $135.2K | |
| Redeemable Common Stock Accretion To Redemption Value | ||
| Deferred Underwriting Fee Payable | $6.6M | |
| Deferred Offering Costs Paid Through Promissory Note Related Party | $7.6K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $32.2K | |
| Cash And Cash Equivalents At Carrying Value | ||
| Offering Costs Paidand Excludedfrom Accrued Offering Costsat Initial Public Offering | $314.5K | |
| Temporary Equity Carrying Amount Attributable To Parent | $228.1M | $0.00 |
| Cash | ||
| Temporary Equity Accretion To Redemption Value | $18.8M | |
| Offering Costs Included In Accrued Offering Costs |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|
| Stockholders Equity | -$12.4M | -$12.2M | -$12.0M | -$25.1K | |
| Deferred Underwriting Fee | $6.6M | $6.6M | $6.6M | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $141.9K | $240.4K | $356.1K | $0.00 | |
| Retained Earnings Accumulated Deficit | -$12.5M | -$12.2M | -$12.0M | ||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | ||
| Notes Payable Current | $0.00 | $0.00 | $0.00 | ||
| Liabilities Current | $230.5K | $157.3K | $109.6K | ||
| Liabilities And Stockholders Equity | $226.2M | $223.9M | $221.8M | ||
| Liabilities | $12.8M | $12.8M | $12.7M | ||
| Deferred Costs | $0.00 | $0.00 | $0.00 | ||
| Assets Held In Trust Noncurrent | $225.9M | $223.4M | $221.1M | ||
| Assets Current | $329.3K | $459.8K | $594.4K | ||
| Assets | $226.2M | $223.9M | $221.8M | ||
| Advisory Fee Payable | $6.0M | $6.0M | $6.0M | ||
| Accrued Liabilities Current | $143.6K | $70.4K | $22.7K | ||
| Accounts Payable Underwriters Promoters And Employees Other Than Salaries And Wages Current | $86.9K | $86.9K | $86.9K | ||
| Repayments Of Related Party Debt | $135.2K | $0.00 | |||
| Redeemable Common Stock Accretion To Redemption Value | -$2.5M | -$2.3M | -$11.8M | ||
| Deferred Underwriting Fee Payable | $6.6M | $0.00 | |||
| Deferred Offering Costs Paid Through Promissory Note Related Party | $7.6K | $0.00 | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $356.1K | $0.00 | |||
| Cash And Cash Equivalents At Carrying Value | $141.9K | $240.4K | $356.1K | $0.00 | |
| Offering Costs Paidand Excludedfrom Accrued Offering Costsat Initial Public Offering | $0.00 | ||||
| Temporary Equity Carrying Amount Attributable To Parent | |||||
| Cash | $141.9K | $240.4K | $356.1K | $0.00 | |
| Temporary Equity Accretion To Redemption Value | |||||
| Offering Costs Included In Accrued Offering Costs | $314.5K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 |
|---|---|
| Proceeds From Issuance Initial Public Offering | $219.8M |
| Proceeds From Issuance Of Private Placement | $1.8M |
| Payments To Acquire Marketable Securities | $220.0M |
| Payments Of Stock Issuance Costs | $490.5K |
| Net Cash Provided By Used In Operating Activities | -$842.1K |
| Net Cash Provided By Used In Investing Activities | -$220.0M |
| Net Cash Provided By Used In Financing Activities | $220.9M |
| Increase Decrease In Prepaid Expense | $156.7K |
| Increase Decrease In Long Term Prepaid Insurance | $14.6K |
| Increase Decrease In Accrued Liabilities | $1.3M |
| Increase Decrease In Advisory Fee Payable | $6.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q3 2024 |
|---|---|---|
| Proceeds From Issuance Initial Public Offering | $219.8M | $0.00 |
| Proceeds From Issuance Of Private Placement | $1.8M | $0.00 |
| Payments To Acquire Marketable Securities | $220.0M | $0.00 |
| Payments Of Stock Issuance Costs | $490.5K | $0.00 |
| Net Cash Provided By Used In Operating Activities | -$518.2K | $0.00 |
| Net Cash Provided By Used In Investing Activities | -$220.0M | $0.00 |
| Net Cash Provided By Used In Financing Activities | $220.9M | $0.00 |
| Increase Decrease In Prepaid Expense | $238.3K | $0.00 |
| Increase Decrease In Long Term Prepaid Insurance | $126.1K | $0.00 |
| Increase Decrease In Accrued Liabilities | -$12.3K | $0.00 |
| Increase Decrease In Advisory Fee Payable | $6.0M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 |
|---|---|---|
| Preferred Stock Shares Outstanding | 0.00 | 0.00 |
| Preferred Stock Shares Issued | 0.00 | 0.00 |
| Preferred Stock Shares Authorized | 1.0M | 1.0M |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Authorized | 1.0M | 1.0M | 1.0M |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 |
|---|---|---|
| Prepaid Insurance Non Current | $14.6K | $0.00 |
| Prepaid Expense Current | $156.7K | $0.00 |
| Noninterest Expense Investment Advisory Fees | $6.0M | |
| Investment Income Interest | $8.1M | |
| Additional Paid In Capital | $0.00 | $24.4K |
| Forfeiture Of Founder Shares | 25.00 | |
| Stock Issued During Period Value Restricted Stock Award Forfeitures | $0.00 | |
| Sale Of Shares To Sponsor In Private Placement Value | 1.8M | |
| Payment Of Operation Costs Through Promissory Note | $0.00 | |
| Formation Costs Paid By Sponsor In Exchange For Issuance Of Ordinary Shares | 0.00 | |
| Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | $117.4K | |
| Adjustments To Additional Paid In Capital Fair Value Of Rights Included In Public Units | $3.2M | |
| Adjustments To Additional Paid In Capital Fair Value Of Contingent Rights Included In Public Units | $80.3K | |
| Other Operating Income Expense Net | ||
| Stock Issued During Period Value Issued For Services |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 |
|---|---|---|---|---|
| Prepaid Insurance Non Current | $51.7K | $88.9K | $126.1K | |
| Prepaid Expense Current | $187.4K | $219.4K | $238.3K | |
| Noninterest Expense Investment Advisory Fees | $0.00 | $0.00 | $6.0M | $0.00 |
| Investment Income Interest | $2.5M | $2.3M | $1.1M | $0.00 |
| Additional Paid In Capital | $0.00 | $0.00 | $0.00 | |
| Forfeiture Of Founder Shares | 25.00 | 0.00 | ||
| Stock Issued During Period Value Restricted Stock Award Forfeitures | $0.00 | |||
| Sale Of Shares To Sponsor In Private Placement Value | 1.8M | |||
| Payment Of Operation Costs Through Promissory Note | -$38.3K | |||
| Formation Costs Paid By Sponsor In Exchange For Issuance Of Ordinary Shares | 11.8K | |||
| Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | $117.4K | |||
| Adjustments To Additional Paid In Capital Fair Value Of Rights Included In Public Units | $3.2M | |||
| Adjustments To Additional Paid In Capital Fair Value Of Contingent Rights Included In Public Units | $80.3K | |||
| Other Operating Income Expense Net | $2.3M | $1.1M | ||
| Stock Issued During Period Value Issued For Services | $25.0K |
Most recent annual filing with the SEC: March 19, 2026
Data sourced from SEC EDGAR public filings as of August 4, 2026.